Committee and Working Group (WG) teleconference schedule (all times are U.S. ET)
|Steering Committee||1st Monday of the month at 5:00pm ET||Mark Jenkins|
|Biospecimen WG||3rd Thursday of the month at 5:00pm ET||Teresa Selander|
|Coordinators WG||2nd Wednesday of the month at 5:00pm ET||Allyson Templeton|
|Gene Discovery/Type X WG||3rd Mon of each odd-numbered month at 5:00pm ET||Daniel Buchanan|
|Molecular Characterization WG||3rd Mon of each even-numberd month at 5:00pm ET||Daniel Buchanan|
|Technical WG||4th Tuesday of the month at 5:00pm ET||Maggie Angelakos|
Next in-person meeting
|What||Colon Cancer Family Registry Annual In-person Steering Committee Meeting|
|When||2021, to be determined. Due to COVID-19, the Nov 2020 meeting has been canceled. The date of the next meeting remains to be determined.|
To be determined
|Agenda||To be determined|
The Colon Cancer Family Registry has served as an international resource for studies of the genetics and epidemiology of colorectal cancer (CRC) since 1997. It is the largest single family-based resource in the world for the study of CRC (and other cancers, such as endometrial cancer, that occur in these families). The CCFR has supported and facilitated over 200 scientific projects, many including collaborations with other top CRC groups in the world, and has generated over 400 publications to date. This annual in-person meeting enhances the monthly one-hour Steering Committee and other working group conference calls.
These in-person meetings provide the opportunity for more in-depth discussions, break-out sessions, and concentrated impromptu meetings, all of which benefit the research agenda, scope of work, and the collaborative focus of the Colon Cancer Family Registry Cohort. Discussions focus on reviewing ongoing projects, updates on progress on the scope of work, brainstorming on novel scientific ideas and evaluation of opportunities for collaborating with other consortia as a group. These meetings are also focused on the genesis and development of new grant proposals which complement and further the aims of the cohort.